Your browser doesn't support javascript.
loading
Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinib.
Mesa, Ruben; Verstovsek, Srdan; Platzbecker, Uwe; Gupta, Vikas; Lavie, David; Giraldo, Pilar; Recher, Christian; Kiladjian, Jean-Jacques; Oh, Stephen T; Gerds, Aaron T; Devos, Timothy; Passamonti, Francesco; Vannucchi, Alessandro M; Egyed, Miklos; Lech-Maranda, Ewa; Pluta, Andrzej; Nilsson, Lars; Shimoda, Kazuya; McLornan, Donal; Kawashima, Jun; Klencke, Barbara; Huang, Mei; Strouse, Bryan; Harrison, Claire.
Afiliación
  • Mesa R; Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston Salem, NC. rmesa@wakehealth.edu.
  • Verstovsek S; The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Platzbecker U; Leipzig University Hospital, Leipzig.
  • Gupta V; Princess Margaret Cancer Centre, Toronto, Ontario.
  • Lavie D; Hadassah-Hebrew University Medical Center, Jerusalem.
  • Giraldo P; Miguel Servet University Hospital and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Zaragoza.
  • Recher C; Institut Universitaire du Cancer de Toulouse, Université de Toulouse III, Toulouse.
  • Kiladjian JJ; Université Paris Cité, AP-HP, Ho_pital Saint-Louis, Centre d'Investigations Cliniques, INSERM, CIC1427, Paris.
  • Oh ST; Washington University School of Medicine, St. Louis, MO.
  • Gerds AT; Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.
  • Devos T; Department of Hematology, University Hospitals Leuven and Department of Microbiology and Immunology, Laboratory of Molecular Immunology (Rega Institute), KU Leuven, Leuven, Belgium.
  • Passamonti F; University of Insubria, Varese.
  • Vannucchi AM; University of Florence and AOU Careggi, Florence.
  • Egyed M; Somogy County Mór Kaposi General Hospital, Kaposvár, Hungary.
  • Lech-Maranda E; Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
  • Pluta A; Department of Hematological Oncology, Oncology Specialist Hospital, Brzozow, Poland.
  • Nilsson L; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden.
  • Shimoda K; University of Miyazaki, Miyazaki, Japan.
  • McLornan D; Guy's and St Thomas' NHS Foundation Trust, London.
  • Kawashima J; Sierra Oncology, Inc., San Mateo, CA.
  • Klencke B; Sierra Oncology, Inc., San Mateo, CA.
  • Huang M; Sierra Oncology, Inc., San Mateo, CA.
  • Strouse B; Sierra Oncology, Inc., San Mateo, CA.
  • Harrison C; Guy's and St Thomas' NHS Foundation Trust, London.
Haematologica ; 109(2): 676-681, 2024 Feb 01.
Article en En | MEDLINE | ID: mdl-37259556
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pirazoles / Benzamidas / Mielofibrosis Primaria Límite: Humans Idioma: En Revista: Haematologica Año: 2024 Tipo del documento: Article País de afiliación: Nueva Caledonia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pirazoles / Benzamidas / Mielofibrosis Primaria Límite: Humans Idioma: En Revista: Haematologica Año: 2024 Tipo del documento: Article País de afiliación: Nueva Caledonia